Beth Shaz | Chief Medical Officer
New York Blood Center

Beth Shaz, Chief Medical Officer, New York Blood Center

Beth Shaz, MD, is chief medical officer, senior vice president of Medical Programs and Services and co-director of the Lindsey F. Kimball Research Institute at New York Blood Center (NYBC).  She is responsible for all medical activities, including hemophilia services, transfusion services, cellular therapy laboratory, stem cell donor recruitment, retention and collection, perioperative autologous transfusion, and therapeutic apheresis. Beth is leading NYBC’s recently launched Comprehensive Cell Solutions. CCS will be focused on developing, improving, and implementing regenerative medicine, cell therapies, transfusion medicine, and related scientific and medical endeavors by more fully integrating basic, translational, applied and clinical research supporting and augmenting the medical, clinical and operational areas.  
She serves also as a clinical associate professor at Emory University School of Medicine and Adjunct Assistant Professor of Pathology and Cell Biology at Columbia University. Previously, she was an associate professor at Emory School of Medicine and director of the transfusion service at Grady Memorial Hospital and the program director for the Center of Transfusion and Cellular Therapies Blood Banking/Transfusion Medicine Fellowship. In addition, she was an instructor at Harvard Medical School and served as associate director of the transfusion service and director of the transfusion/pheresis unit at Beth Israel Deaconess Medical Center in Boston.
As a member of the Lindsey F. Kimball Research Institute, her laboratory is focused on developing novel blood products, including products derived from blood and stem cells. Beth has received funding from the National Institutes of Health and the National Blood Foundation regarding blood donation in underrepresented minorities. She was an active member of the College of American Pathologists and has been a board member, committee chair and active committee member of the American Society for Apheresis. An active AABB member, Beth was on the Board of Directors and was a member of the National Blood Foundation board. Currently she is on the board of the Cord Blood Association.
Beth has published more than 160 peer-reviewed articles, editorials and book chapters, is an associate editor of "Transfusion" and co-editor of the first and second editions of "Transfusion Medicine and Hemostasis: Clinical and Laboratory Aspects," "Guidelines for Patient Blood Management and Blood Utilization," and "Look This Up Too! (A Quick Reference in Apheresis)" — the first and second editions. Additionally, Beth serves on the editorial board of “Blood”.
Beth received her medical degree with research distinction from the University of Michigan Medical School-Ann Arbor and a Bachelor of Science degree in chemical engineering with distinction from Cornell University.


Conference Day 2: Friday 17th May 2019 @ 09:00

Using the whole cord blood to make novel therapies

  • Use of umbilical cord blood cells for immunotherapies
  • Potential uses of cord blood plasma and platelets
  • Uses of cord blood derived mesenchymal stem cells
last published: 14/May/19 13:35 GMT

back to speakers

The World Advanced Therapies and Regenerative Medicine Congress and Exhibition is an international conference and exhibition featuring the latest in advanced therapies, bioengineering and surrounding technology. To attend the conference which features global leaders in the biopharma and regenerative medicine industries, there is a registration fee. The exhibition is free to visit.

Register your pass here.